Clinical Trials Directory

Trials / Completed

CompletedNCT00571623

Automated Chest Physiotherapy to Improve Outcomes in Neuro

Automated Chest Physiotherap to Improve Outcomes in Neurocritical Care: An Intracranial Pressure Study

Status
Completed
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Following current standard-of-care, subjects data (brain pressure) will be recorded for 1 hour and include 10-minutes of data during which the subject recieves chest physiotherapy (CPT). The hypothesis is that CPT is not harmful to brain pressure.

Detailed description

The purpose of this study is to examine the effect of chest physiotherapy (CPT) on intracranial pressure (ICP). Because CPT is a normal part of the routine care provided to patients in the neurocritical care unit (NCU) this is an observational study of current practice. 1. The purpose of this study is to examine the effect of chest physiotherapy (CPT) on intracranial pressure (ICP). Because CPT is a normal part of the routine care provided to patients in the neurocritical care unit (NCU) this is an observational study of current practice. 2. The study will include only patients who currently have intracranial pressure monitoring devices in place (intraventricular and intraparenchymal). The study will last 1-hour and all subjects in the study will receive 10-minutes of CPT. The 10-minute CPT episode will be randomly assigned to occur 10, 20, 30 or 40-minutes into the study. 3. ANCOVA using SAS will be used to explore for within and between group differences in ICP. This study observes current standard practice, there are no additional risks to the subject.

Conditions

Interventions

TypeNameDescription
OTHERChest Physiotherapy10-minutes of chest physiotherapy using programmed parameters that are components of the specialty beds used in ICU

Timeline

Start date
2007-09-01
Primary completion
2008-03-01
Completion
2008-03-01
First posted
2007-12-12
Last updated
2014-07-09

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00571623. Inclusion in this directory is not an endorsement.